Table 2 Epidemiological and clinical characteristics comparing IATM versus MS group
From: Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series
IATM | MS | p | |
|---|---|---|---|
group | group | ||
N (%) | 74 (87) | 11 (13) | |
Age, mean (SD), y | 45 (16) | 28.2 (9.1) | 0.001 a |
Sex, male/female | 36/38 | 4/7 | 0.529 |
Follow up, median (IQR), y | 2.9 (0.9–3.9) | 9.9 (2.7–17.8) | <0.001 a |
Time to maximum deficit, mean (SD), d | 6.9 (7.2) | 8.5 (7) | 0.487 |
Admission Rankin, Mean (SD) | 2.8 (1.2) | 2.45 (1.1) | 0.284 |
Outcome Rankin Mean (SD) | 1.3 (1.3) | 1.8 (1.2) | 0.290 |
Time onset-start treatment, mean (SD), d | 9 (8.1) | 2 (2.2) | 0.553 |
Back pain, n (%) | 30 (40.5) | 5 (45.5) | 0.755 |
Urinary sphincter dysfunction, n (%) | 41 (55.4) | 6 (54.5) | 0.603 |
Anal sphincter dysfunction, n (%) | 10 (13.5) | 1 (9.1) | 0.566 |
Previous infection, n (%) | 23 (31.1) | 4 (36.4) | 0.485 |
Summer season/Not summer season, n (%) | 13/72(18.1)/59/72 (81.9) | 1/11 (9.1)/10/11 (90.9) | 0.460 |
TM relapses, n (%) | 0/73 (0) | 5/11 (45.5) | <0.001 a |